PLAU anticorps (C-Term)
Aperçu rapide pour PLAU anticorps (C-Term) (ABIN2383128)
Antigène
Voir toutes PLAU AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 396-426, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Urokinase Plasminogen Activator, CT (PLAU, plasminogen activator, urokinase, HGNC:9052, ATF, UPA, URK, u-PA , U-plasminogen activator, antagonist of uPA, plasminogen activator, urinary, urokinase plasminogen activator, urokinase-type plasminogen activator amino-terminal fragment, urokinase-type plasminogen activator precursor)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 396-426 in the C-terminal region of human PLAU, UniProt Accession #P00749.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Autre désignation
- Urokinase Plasminogen Activator
-
UniProt
- P00749
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Antigène
-